A Single Arm, Phase Ib Study of RAD001 and Sunitinib in Patients With Advanced Renal Cell Carcinoma
Phase of Trial: Phase I
Latest Information Update: 19 Feb 2015
At a glance
- Drugs Everolimus (Primary) ; Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jun 2011 Planned End Date changed from 1 Oct 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 21 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.